Vaccine Information for Consideration 

Access to all links: https://docs.google.com/document/d/1hRRqXrLnOUsaQjmsV3QRX0JTrZCo0KENQIYGY0prUjg/edit?usp=sharing 

Hepatitis B Vaccine

Hep B disease: Infection of liver. Spread by blood from an infected person.
Dr. Sears says in The Vaccine Book, “The CDC states that Hep B is not spread through casual contact. It is not a childhood disease except for infants born to mothers with Hep B."

Hep B vaccine is given at birth, a second time at 1-2 months, and a third time between 6 and 18 months.


Vaccine brands and package inserts for Hep B for infants:

Engerix-B (manufactured by GlaxoSmithKline)
https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Engerix-B/pdf/ENGERIX-B.PDF

Recombivax HB (manufactured by Merck)
https://www.merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf

Pediarix  (manufactured by GlaxoSmithKline)
(also contains vaccines for diphtheria, tetanus, pertussis, polio) https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Pediarix/pdf/PEDIARIX.PDF

Vaxelis (manufactured by Sanofi Pasteur)
(NEW: approved Dec 2018)
(also contains vaccines for diphtheria, tetanus, pertussis, polio, and HiB)
https://www.fda.gov/downloads/BiologicsBloodVaccines/UCM629109.pdf

Vaccine Concerns:

  • The FDA allows no more than 10-25mcg intravenous (IV) aluminum per day for infants.
    There are no safety studies on the amount of aluminum in intramuscular vaccines.
    The amount of intramuscular (IM) aluminum in the Hep B vaccines is:
    Engerix-B: 250mcg
    Recombivax HB: 250mcg
    Pediarix: 850mcg
    Vaxelis: 319mcg
  • Fever was significantly higher for those who received Pediarix than in children who received separate vaccines, according to the Pediarix package insert, section 6.
  • Questionable ingredients include but are not limited to: formaldehyde, yeast, antibiotics, polysorbate 80, etc.
  • Reported side effects of the Hep B vaccines include but are not limited to:
    Encephalitis (swelling of brain)
    Anaphylactic reaction (difficulty breathing)
    Guillain Barre (partial or complete paralysis)
    Lupus
    Multiple Sclerosis (MS)
    Seizures
    Meningitis

Disease Risk vs. Vaccine Risk:

  • According to the CDC, the risk of acquiring Hepatitis B is 1 in 40,000.
  • The short-term safety study involved 6,400 children with reactions presenting in about 10% of cases, according to The Vaccine Book by Dr. Sears. (Vaccine reaction risk is 1 in 640.)
  • As of July 2018, there have been 88,629 adverse reactions reported to the Vaccine Adverse Event Reporting System (VAERS), with 1,620 deaths occurring in children under age three.
  • As of Aug 2017, there have been 89 deaths and 722 injuries filed with the Vaccine Injury Compensation Program (VICP) concerning Hep B vaccines.

More information:
https://www.nvic.org/vaccines-and-diseases/hepatitis-b/vaccine-injury.aspx

And
https://www.nvic.org/vaccines-and-diseases/hepatitis-b/quick-facts.aspx



Rotavirus Vaccine

Rotavirus disease: intestinal virus causing severe diarrhea. It is spread in stool (unwashed hands after using the bathroom or changing a diaper.) It is common in infants and children in daycare.

Rotavirus vaccine is given once at  2 months and a second time at 4 months. Rotateq requires a third dose at 6 months.  If the first dose of either brand is not given before 12 weeks of age, the child should not receive a rotavirus vaccine at all.
It is an oral vaccine, not an injection.

Vaccine brands and package inserts for Rotavirus  for infants:


Rotarix: (manufactured by GlaxoSmithKline)
https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Rotarix/pdf/ROTARIX-PI-PIL.PDF

Rotateq: (manufactured by Merck)
https://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf

Vaccine Concerns:

  • Live-virus: Both brands of Rotavirus vaccines are live-virus. Babies can be contagious with Rotavirus for up to two weeks after vaccination, according to Dr. Sears. In comparison, according to the CDC, people who have Rotavirus disease are contagious while symptoms show up to three days after recovery.
  • Contaminated: After being put on the market, both brands were discovered to be contaminated with a pig virus. Rotateq is also contaminated with a monkey virus. The CDC says the viruses will not harm humans. However, the CDC also said that the SV40 monkey virus that contaminated the polio vaccine in the 1950s was harmless, but we now know that it has a strong correlation to cancer. It may be unwise to assume these viruses are also harmless and to trust companies that repeatedly contaminate vaccines.
  • Package inserts warn that the virus can shed (be contagious), and caution should be used if the vaccine recipient is around people with immunodeficiencies.
  • Package inserts warn that there is an increased risk of intussusception (intestinal blockage/damage with rotavirus vaccines. Other side effects include but are not limited to inner ear inflammation/infection, cold-like symptoms, diarrhea, vomiting, fever, bronchospasm (asthma and bronchitis-like symptoms), Kawasaki Disease (inflammation of blood vessels), and seizures. Dr. Sears reports that common reactions occur in 10-20% of doses.

Disease Risk vs. Vaccine Risk

  • Rotavirus is a common disease. The disease risk for a severe case in infants is 1 in 200, but is rarely serious after age two. Dr. Sears adds that breastfed infants not in daycare will probably not get rotavirus until they go to school when they are older, when the disease is more mild.
  • If the vaccine has many of the same risks as the disease, in addition to autoimmune diseases, and is a live-virus vaccine, which can shed the disease to others whose vaccines have worn off, to the immunosuppressed, and to younger infants, there is no advantage in getting this vaccine.
  • The CDC says, “Children, even those who are vaccinated, may get infected and sick from rotavirus more than once. That is because neither natural infection with rotavirus nor vaccination provides full protection from future infections.”
  • Between 1990 and 2018, there have been 8,756 serious adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) including 703 deaths in children.
  • As of September 2015, there have been 70 claims filed with the Vaccine Injury Compensation Program (VICP) for serious injury and death after vaccination with the rotavirus vaccine.

Summary:
Severe cases of rotavirus requiring hospitalization have declined since the rotavirus vaccines were introduced. However, most cases of rotavirus are not fatal in the US, since dehydration can be treated. Most infants who are breastfed and not in daycare do not get rotavirus until they are older, when their bodies are more capable of fighting the disease. The vaccines are not 100%, and they do come with risks. In addition, they are contaminated with pig and monkey viruses, and the effects of these are unknown.

DTaP Vaccine

Diphtheria infection: a bacterial infection of the nose and throat spread by airborne droplets (sneezing, coughing, unwashed hands, etc.). Most cases are mild, presenting with a sore throat. (There is no diphtheria-only vaccine.)

Tetanus infection: a bacterial infection that affects the nerves and causes muscle spasms, usually starting in the jaw (lockjaw). The bacteria can be found in soil and animal feces (not rust), and can infect deep puncture wounds. The bacteria then release a toxin, which causes the muscle spasms. There is no cure for tetanus, but there are treatments such as antibiotics, antitoxins, and immunoglobulin. (There is no tetanus-only vaccine.)

Pertussis disease: a bacterial infection of the respiratory tract that causes fits of coughing, which sound like a “whoop,” which is why some call it “whooping cough.” It can be difficult to breathe during these fits. The disease is spread through airborne droplets (coughing, sneezing, etc.). (There is no pertussis-only vaccine)

DTaP vaccine: is given at 2 months, 4 months, 6 months, 15-18 months, and 4-6 years of age.

Vaccine brands and package inserts for DTaP for infants:

Infanrix (manufactured by GlaxoSmithKline)
https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Infanrix/pdf/INFANRIX.PDF

Pediarix  (manufactured by GlaxoSmithKline)
also contains vaccines for hepatitis B and polio) https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Pediarix/pdf/PEDIARIX.PDF

Daptacel (manufactured by Sanofi Pasteur)
https://www.vaccineshoppe.com/image.cfm?doc_id=11179&image_type=product_pdf

Pentacel (manufactured by Sanofi Pasteur)
(also contains vaccines for polio and HiB)
https://www.vaccineshoppe.com/image.cfm?doc_id=13799&image_type=product_pdf

Vaxelis (manufactured by Sanofi Pasteur)
(NEW: approved Dec 2018)
(also contains vaccines for hepatitis B, polio, and HiB)
https://www.fda.gov/downloads/BiologicsBloodVaccines/UCM629109.pdf

Vaccine Concerns:

  • The FDA allows no more than 10-25mcg intravenous (IV) aluminum per day for infants.
    There are no safety studies on the amount of aluminum in intramuscular vaccines.
    The amount of intramuscular (IM) aluminum in the DTaP vaccines is:
    Infanrix: 625mcg
    Pediarix: 850mcg
    Daptacel: 330mcg
    Pentacel: 330mcg
    Vaxelis: 319mcg
  • Reported side effects listed in DTaP package inserts include but are not limited to… respiratory infections, bronchitis, anaphylaxis, coma, apnea, decreased consciousness, seizures, spasms, convulsions, Guillain-Barre Syndrome (paralysis), SIDS, respiratory infection, bulging fontanelle (skull), encephalitis (swelling of brain), abnormal liver function, and more.
  • Side effects listed in studies include eczema and dairy allergies http://www.nvic.org/Vaccines-and-Diseases/Whooping-Cough.aspx 
    And
    https://www.ncbi.nlm.nih.gov/m/pubmed/26707796/ 
    And
    http://www.sciencedirect.com/science/article/pii/S0091674905000266 
  • Infants in the Pediarix safety study who died from SIDS were excluded from the results.
  • Fever was significantly higher for those who received Pediarix than in children who received separate vaccines, according to the Pediarix package insert, section 6.  
  • Epinephrine must be immediately available at time of vaccination in case of severe allergic reaction
  • Seventeen previous DTaP vaccines have been taken off the market in the past, despite first being declared safe. The DTP was recalled due to severe neurological side effects. The Tripedia DTaP, which listed autism in the postmarketing surveillance in the package insert, was recalled.
    https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/b/discontinued_vaccines.pdf
  • Questionable ingredients include but are not limited to… bovine casein (dairy), casamino acids (dairy), glutaraldehyde, formaldehyde, monkey kidney DNA, aluminum, polysorbate 80, neomycin (antibiotic), polymyxin B (antibiotic), yeast, 2-phenoxyethanol, and more.
  • The tetanus toxoid has never been tested for efficacy. The CDC admits to this on their website. (Source: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/tetanus.pdf )

  • Several studies show that a highly virulent strain of pertussis mutated from the vaccine and is causing outbreaks. The vaccine is not effective against this new strain. Twenty-eight of these studies are listed in Miller’s Review of Critical Vaccine Studies.
  • Tdap/Dtap is a killed vaccine, so it cannot directly cause pertussis, but it can cause vaccinated people who come in contact with pertussis to be asymptomatic carriers, thus spreading the disease. Many studies are now showing that the outbreaks are caused by the vaccine. Sources:

Disease Risk vs. Vaccine Risk:

  • Concerning pertussis-containing vaccines, as of June 2018, there have been 150,043 adverse reactions reported to the Vaccine Adverse Event Reporting System (VAERS) since 1990, with 2,745 deaths. Of those deaths, 90% occured in children under age three.
  • Pertussis disease risk: The Vaccine Book by Dr. Sears says this: "Pertussis tends to fall and rise in five-year cycles. There were 25,000 cases reported in 2005, 15,000 cases in 2006, and only 10,000 in 2007. Then in 2010, there were 30,000 cases.” These numbers show that it is a common disease. The disease risk for a severe case of Pertussis is 1 in 3,333 and rarely serious beyond age one. The majority of cases are mild. It involves harmless coughing fits, and the child feels well otherwise. Antibiotics are prescribed, which kill the bacteria and cause the child to no longer be contagious. After a few weeks, the airways heal up, and the coughing stops. Hospitalization happens mostly with infants and premature newborns. A quote from the Dr. Sears book says, "Toddlers and older children do not die from pertussis in the United States" (pg. 32).
  • As of Aug 2017, there have been 862 deaths and 4,507 injuries filed with the Vaccine Injury Compensation Program (VICP) concerning pertussis-containing vaccines.
  • Concerning tetanus-containing vaccines, as of August 2018, there have been 26,834 serious adverse reactions reported to VAERS since 1990. Of these reports, 3,031 were deaths.
  • The Vaccine Book by Dr. Sears (published 2010) says that there are only about 20 cases of tetanus per year in the US due to proper sanitation, hygiene, and wound care. Compare these 20 cases of the disease per year with the 26,834 adverse events of the vaccine since 2012.

  •  According The Vaccine Book by Dr. Sears, there are only about 5 cases of diphtheria each year in the US, and the last case reported was in 2003. It is extremely rare.  Only 10% of cases are fatal. Most cases are a simple sore throat that requires no treatment.

Summary:
DTaP is a risky vaccine that doesn’t prevent disease well. Tetanus and diphtheria are not common diseases, and the tetanus vaccine has many adverse reactions and deaths reported with VAERS and filed with VICP. Pertussis is a common disease and is mostly dangerous for infants under 12 months of age. However, thousands of reactions and deaths have been reported to VAERS and filed with VICP for pertussis-containing vaccines. The CDC has information showing that infants not given the full round of DTaP are less likely to contract pertussis, and the FDA has studies showing that the vaccine may be contributing to outbreaks. This is demonstrated in California, where DTaP is mandated, but there are still pertussis outbreaks. Parents can reasonably choose to avoid DTaP and focus on hygiene and nutrition to strengthen their infant’s immune system.

More information:






HiB Vaccine

Haemophilus influenzae type B: a bacterial infection that can cause blood, bone, and throat infections, pneumonia, and meningitis. It is spread like the common cold. There are many types of haemophilus influenzae; type B is one of them.

HiB Vaccine: the dose depends on the brand.
ActHIB, Hiberix, and Pentacel are given in four doses at ages 2 months, 4 months, 6 months, and 12-15 months.

PedvaxHIB is given in three doses at ages 2 months, 4 months, and 12-15 months.

Vaxelis is given in three doses at ages 2 months, 4 months, and 6 months.

Vaccine brands and package inserts for HiB for infants:

ActHIB (manufactured by Sanofi Pasteur)

https://www.vaccineshoppe.com/image.cfm?doc_id=13692&image_type=product_pdf

Hiberix (manufactured by GlaxoSmithKline)

https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Hiberix/pdf/HIBERIX.PDF

PedvaxHIB (manufactured by Merck)

https://www.merck.com/product/usa/pi_circulars/p/pedvax_hib/pedvax_pi.pdf

Pentacel (manufactured by Sanofi Pasteur)
(also contains vaccines for diphtheria, tetanus, pertussis, and polio)
https://www.vaccineshoppe.com/image.cfm?doc_id=13799&image_type=product_pdf

Vaxelis (manufactured by Sanofi Pasteur) 
(NEW: approved Dec 2018)
(also contains vaccines for hepatitis B, diphtheria, tetanus, pertussis, and polio)
https://www.fda.gov/downloads/BiologicsBloodVaccines/UCM629109.pdf

Vaccine Concerns:

  • The FDA allows no more than 10-25mcg intravenous (IV) aluminum per day for infants.
    There are no safety studies on the amount of aluminum in intramuscular vaccines.
    The amount of intramuscular (IM) aluminum in the HiB vaccines is:
    ActHIB: 0mcg
    Hiberix: 0mcg
    PedvaxHIB: 225mcg
    Pentacel: 330mcg
    Vaxelis: 319mcg
  • Strain replacement has increased since vaccination campaigns for HiB. More strains of haemophilus influenzae (not type B) are now causing pediatric meningitis.
    https://www.drpaulapproved.com/vaccines--strain-replacement-haemophilus-influenza.html
  • Ingredients of concern: casein (dairy), formaldehyde,
  • Question: Why do ActHIB and Hiberix contain the tetanus toxoid, and why do these vaccines not count as tetanus vaccination?
  • Reported side effects include but are not limited to:
    seizure/convulsion, apnea, diarrhea, vomiting, ear infection, upper respiratory infection, rash, early onset HiB disease, meningitis, Guillain-Barré Syndrome, etc.

Disease Risk vs. Vaccine Risk:

  • Mild cases need no medical attention, moderate cases need antibiotics, and severe cases have a 5% fatality. There are about 25 cases in the US each year, mostly in children under age 2. Risk of a severe case of HIB in children under 2 is 1 in 200,000. Risk of a severe case after age 2 is close to 0. (Source: The Vaccine Book by Dr. Sears)
  • As of April 2019, there have been 79,766 adverse reactions reported to the Vaccine Adverse Event Reporting System (VAERS) with 88% of those in children under age three. Of those reactions, 2,674 were deaths, and 93% of those deaths were in children under age three.

Summary: The risk of contracting a serious case of HiB is extremely low. The vaccine is causing strain replacement, and the vaccine can cause meningitis and other side effects that are similar to the disease the vaccine is meant to prevent.


Pneumococcal Conjugate Vaccine

Pneumococcus (Streptococcus pneumoniae): a bacterial infection ranging from mild cold and ear infections to pneumonia, bloodstream infections, and meningitis. It is treated with antibiotics.

PCV13 Vaccine: is given at 2, 4, 6, and 12-15 months of age. There is only one brand for infants on the market at the time of this writing.

Vaccine brand and package insert for infants:

Prevnar 13 (manufactured by Pfizer)
http://labeling.pfizer.com/showlabeling.aspx?id=501

Vaccine Concerns:

  • Strain Replacement:
  •  Prevnar 7 was the old vaccine which covered seven strains of streptococcus pneumoniae. Prevnar 7 was found to cause in increase in the likelihood of catching strains not covered by the vaccine; it caused new strains to emerge.
  • Prevnar 13 was approved in 2010 and covers 13 strains (64%) of streptococcus pneumoniae, but more strains continue to emerge as vaccine use increases.
  • According to Miller’s Review of Critical Vaccine Studies, studies have shown that Prevnar 13 is causing worse cases of antibiotic-resistant pneumococcal disease, making it more difficult to treat.
  • Reported side effects include but are not limited to:
    Apnea, Hypotonia (weak muscles, “floppy baby syndrome”), Cyanosis (blue skin due to low blood oxygen levels), Seizures, Meningitis, Anaphylactic shock, SIDS
  • Ingredients of concern: diphtheria protein, aluminum
  • The amount of intramuscular (IM) aluminum in PCV13 is 125mcg.The FDA allows no more than 10-25mcg intravenous (IV) aluminum per day for infants.
    There are no safety studies on the amount of aluminum in intramuscular vaccines.

Disease Risk vs. Vaccine Risk:

  • Mild cases pass without medical care. There are about 2,000 severe cases in the US each year.  Disease risk is about 1 in 2,850 children under age two. (Source: The Vaccine Book by Dr. Sears)
  • As of April 2019, there have been 58,451 adverse reactions have been reported to the Vaccine Adverse Event Reporting System (VAERS) with 70% of those occurring in children under age three. Of those reports, 1,745 were deaths with 85% occurring in children under age three.
  • As of September 1, 2015, there had been 47 claims filed in the Vaccine Injury Compensation Program (VICP) for injuries and deaths following pneumococcal vaccinations, including 6 deaths and 41 serious injuries.
  • Severe reaction to the vaccine occurs in 8% of recipients. (Source: The Vaccine Book by Dr. Sears)

Summary: Streptococcus pneumoniae can be treated with antibiotics. The disease risk is in the middle. The risk of contracting this disease is higher than HiB, polio, diphtheria, tetanus, and hepatitis B. The risk of contracting Streptococcus pneumonia is significantly lower than rotavirus and pertussis. However, there are more than 90 pneumococcal strains, and this vaccine was designed to protect against only 13 strains. In addition, mass use of this vaccine has contributed to more cases of strains not included in the vaccine and strains that are resistant to bacteria. The vaccine is not without side effects, has reported fatalities, and contains aluminum.


More Information:
https://www.nvic.org/Vaccines-and-Diseases/Pneumococcal.aspx


Polio Vaccine

Poliomyelitis Disease: an enterovirus that lives in the gut. It is transmitted like the common cold or through the stool of an infected person.

Polio Vaccine: the first dose is given at 2 months, the second dose at 4 months, the third dose anytime between 6 and 18 months, and the fourth dose anytime between 4 and 6 years of age.

Vaccine brands and package inserts for polio vaccine for infants:

IPOL (manufactured by Sanofi Pasteur)
https://www.vaccineshoppe.com/image.cfm?doc_id=5984&image_type=product_pdf

Pediarix  (manufactured by GlaxoSmithKline)
(also contains vaccines for hepatitis B, diphtheria, tetanus, and pertussis) https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Pediarix/pdf/PEDIARIX.PDF

Pentacel (manufactured by Sanofi Pasteur)
(also contains vaccines for diphtheria, tetanus, pertussis, and HiB)
https://www.vaccineshoppe.com/image.cfm?doc_id=13799&image_type=product_pdf

Vaxelis (manufactured by Sanofi Pasteur)
(NEW: approved Dec 2018)
(also contains vaccines for hepatitis B, diphtheria, tetanus, pertussis, and HiB)
https://www.fda.gov/downloads/BiologicsBloodVaccines/UCM629109.pdf

Vaccine Concerns:

  • The FDA allows no more than 10-25mcg intravenous (IV) aluminum per day for infants.
    There are no safety studies on the amount of aluminum in intramuscular vaccines.
    The amount of intramuscular (IM) aluminum in the polio vaccines is:
    IPOL: 0mcg
    Pediarix: 850mcg
    Pentacel: 330mcg
    Vaxelis: 319mcg
  • Other ingredients of concern: cow DNA, monkey DNA, and formaldehyde.
  • History of unsafe polio vaccines: A previous polio vaccine was first declared safe, then found to be contaminated with the SV40 virus, which is a virus found in some human cancers. According to the National Center for Biotechnology Information, “There may be an increased incidence of certain cancers among the 98 million persons exposed to contaminated polio vaccine in the U.S.; further investigations are clearly justified.” https://www.ncbi.nlm.nih.gov/pubmed/10472327/
    Can we be sure that there is no contamination of similar viruses in the current vaccine? (The current Rotavirus vaccines are contaminated with similar viruses.) Can we be sure that the current vaccine does not have a role in causing cancer? In addition, despite the vaccine containing carcinogenic ingredients (such as formaldehyde), the package insert informs that the vaccine has not been tested for carcinogenicity. (In fact, no vaccine has been tested for a correlation to cancer.)
  • Fever was significantly higher for those who received Pediarix than in children who received separate vaccines, according to the Pediarix package insert, section 6.
  • Vaccine-derived poliovirus: Countries with polio vaccine campaigns are seeing a rise in childhood paralysis and vaccine-derived poliovirus. Although this has occurred in some places in the US, where the inactivated polio vaccine (IPV) is used, it has mostly occurred in countries using the oral polio vaccine (OPV), such as India and Syria. In fact, more children are now being paralyzed by the OPV than by polio.
    https://www.npr.org/sections/goatsandsoda/2017/06/28/534403083/mutant-strains-of-polio-vaccine-now-cause-more-paralysis-than-wild-polio
    And
    https://www.pbs.org/newshour/world/polio-outbreak-reported-syria
    And
    https://thevaccinereaction.org/2015/07/india-still-reporting-cases-of-polio-like-acute-flaccid-paralysis/
    And “    Polio is another vaccine that is completely unwarranted. Although you may associate polio with the paralysis, iron lungs, and deaths of the mid-1900s epidemic, this disease was eradicated decades ago. Today, you’re much more likely to get it from the vaccine than to contract ‘wild’ polio.” - Julian Whitaker, MD
    https://www.nvic.org/Doctors-Corner/JulianWhitakerMD/The-Truth-About-Vaccinations.aspx
    And
    Miller’s Review of Critical Vaccine Studies, pg 166, lists studies that have shown that thousands of children were paralyzed after vaccine campaigns. A study showed that regions in India where children who were vaccinated multiple times for polio had a rate for paralysis 35 times higher than normal. Children who became paralyzed after the vaccine had twice the risk of dying compared to children who contracted polio.
  • The credit for eradicating polio in America has been given to polio vaccinations. However, there are other factors to consider in the eradication of polio:
  • First, DDT (an insecticide) was found to cause polio-like symptoms. Its use was widespread in America, and at this time, polio diagnoses were on the rise. Polio diagnoses decreased in America and Europe when DDT was banned. However, only America had a widespread polio vaccine program.
  • Second, after the polio vaccine was introduced, the diagnostic criteria for polio changed. The first polio vaccine was available in 1955. At that time, a person with symptoms was evaluated by a doctor and then evaluated a second time 48 hours later. If that person still had symptoms, he was diagnosed with paralytic polio, even if he made a full recovery shortly afterwards. By 1957, the diagnostic criteria had changed to two exams 60 days apart. So if a person showed symptoms for 48 hours in 1955, he was diagnosed with paralytic polio. If a person showed symptoms for 48 hours in 1957, he was not diagnosed with paralytic polio. This change in diagnostic procedure would cause a significant decrease in polio cases. Today, testing is done to determine between diseases that show similar symptoms to polio, such as acute flaccid paralysis (AFP), Guillain-Barre Syndrome (GBS), meningitis, and West Nile. To summarize: the same amount of people are sick with polio symptoms, but they are diagnosed differently today.

Disease Risk vs. Vaccine Risk

  • According to Dr. Sears, “No American has had polio since 1979. The disease risk in America is zero.”
  • According to the CDC, for those who do contract polio, most do not show symptoms. In 25% of cases, there are flu-like symptoms which last two to five days. Paralysis occurs in about 1% of cases and is usually temporary.
  • As of April 2019, there have been 98,635 adverse reactions reported to the Vaccine Adverse Event Reporting System. Of those reports, 2,748 of those were deaths. Of those deaths, 89% were in children under age three.

Summary: Polio can have very serious paralysis and can be fatal, but this is extremely rare. About 75% of people who contract polio do not experience any symptoms. Polio has not been reported in America in 40 years. Meanwhile, more children experience paralysis from the vaccine than the disease. Parents can reasonably choose to decline the polio vaccine for these reasons.

Measles, Mumps, Rubella Vaccine

Measles Disease: causes a fever, red rash, red eyes, runny nose, cough. Symptoms are similar to other illnesses, so a blood test is used to diagnose. A mild case lasts about a week. A moderate case may involve ear infection, pneumonia, or other complications and a higher fever. This is uncommon. A severe case is very rare but may cause encephalitis (brain inflammation) or severe pneumonia. Approximately 1 in 1,000 measles cases is fatal. The disease can be treated with high dose vitamin A. The disease usually creates lifelong immunity. (The Vaccine Book by Dr. Sears, pg 81-82)

Mumps Disease: a virus that causes fever and swelling of saliva glands in the cheeks. Most cases in children are so mild that a minor fever and sore throat are the only symptoms. A moderate case has a higher fever, swollen facial glands, and fatigue that lasts for several days. Teens and young adults are more likely to have moderate cases. No treatment is necessary. Severe cases are rare but unpredictable, involving swelling of testicles or ovaries that can cause infertility. Arthritis, kidney problems, heart problems, brain dysfunction, and deafness are other possible complications in a serious case. Such severe cases are virtually unheard of in children prior to puberty. The disease creates lifelong immunity. (Sears, 82)

Rubella Disease: a virus that causes fever and rash, aching joints, swollen glands behind the ears and in the neck. A blood test can confirm the diagnosis. Most cases are so mild in children and adults that the fever and rash come and go without diagnosis or a doctor visit. Moderate cases are rare, and the virus does not cause severe cases. Pregnant women who have never had the disease, haven’t been vaccinated, or have had the vaccine wear off are at risk of birth defects for the unborn child. The disease creates lifelong immunity. (Sears, 83-84)

MMR Vaccine is given at 12 or 15 months of age and a second time at 4 to 6 years of age.

Vaccine brands and package inserts for MMR:
MMRII (manufactured by Merck)
https://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf 

ProQuad (manufactured by Merck)
(Also contains vaccine for chickenpox)
https://www.merck.com/product/usa/pi_circulars/p/proquad/proquad_pi_4171.pdf 

Vaccine Concerns:

  • Egg allergies: MMRII and ProQuad are made from chick embryos. The package inserts state to use with caution in those who have egg allergies. However, studies show that food proteins that bypass the digestive system and are instead injected can create food allergies, especially when those food proteins were both eaten and injected. (The Peanut Allergy Epidemic by Heather Fraser, pgs. 93-94)
  • Gelatin allergies: Bovine serum and gelatin are also in the vaccines. Japanese doctors have acknowledged that injecting gelatin can cause gelatin allergies. (The Peanut Allergy Epidemic by Heather Fraser, pg. 129)

  • Aborted fetal DNA is in these vaccines. WI-38 was taken from a 3 month gestation baby girl, and is used in both these vaccines for the rubella portion. MRC-5 is also in ProQuad for the chickenpox portion. MRC-5 was created from a 14 week gestation baby boy. Dr. Theresa Deisher explains that the amount of DNA needed to trigger labor is 0.46 - 5.08 ng/mL. The amount of foreign DNA in Merck’s MMR and varicella vaccines can reach up to 5 ng/mL. This is enough to trigger an autoimmune response. She goes on to say that individuals with autism have antibodies against human DNA in their blood that non-autistic individuals do not have. Autism rates started climbing in 1981. The rubella portion of the vaccine used to be made from duck embryos but was changed to aborted human embryos in 1979.
    https://soundchoice.org/our-research/open-letter-to-legislators/ 
    Aborted fetal DNA is a religious concern but also a medical concern due to autoimmune disease. Dr. Sears explains that the body can recognize foreign animal DNA and have an immune response to it, but human DNA is too similar to one’s own DNA, and it therefore causes an autoimmune response. (Sears, pg. 232)
  • History of abortion: Package inserts state that it is not known whether the vaccine will be dangerous in pregnancy. Yet, pregnant mothers who were accidentally given MMR  were told to abort their babies because they would have birth defects. https://cogforlife.org/vaccines-abortions/ 
  • Contamination: Package insert says MMR has been tested for adventitious agents, but this was proven false in the Corvelva study, which found other viruses in higher amounts than the rubella virus. Meanwhile, the rubella portion may be too low to create any immunity. Corvelva also found an entire human genome from MRC-5, and many of the genes are abnormal with 560 of them being carcinogenic.
    https://www.corvelva.it/en/speciale-corvelva/vaccinegate-en/what-did-we-find-in-the-mmrv-priorix-tetra-vaccine.html 
  • Both ProQuad and MMRII contain neomycin (antibiotic). (Section 11 of package inserts)

  • ProQuad contains MSG. (Section 11 of package inserts)
  • ProQuad has a higher risk of seizures compared to MMRII and Varivax given separately. (see first page of package insert)
  • Unknown ingredients: The package inserts for both vaccines say they contain “other buffer and media ingredients” What are these? Why are they unlisted? (see package inserts, section 11)

  • Efficacy Study for MMRII was very small, with only 284 children aged 11 months to 7 years. The study for 6 month and 15 month old children does not say how many children were in the study. (see package insert section 14)
  • Safety Studies: the Cochrane Collaborative reported that “The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate.” https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub3/abstract 
  • MMRII is a triple live virus vaccine, and ProQuad is a quadruple live virus vaccine. Live virus vaccines do have the potential to cause the disease they vaccinate against and shed the disease to others. Four viruses are a lot for the body to handle all at once. Dr. Sears and many other pediatricians preferred to give these vaccines separately, but they are no longer manufactured separately.
    https://www.ncbi.nlm.nih.gov/pubmed/11858860
    https://www.ncbi.nlm.nih.gov/pubmed/20822734
  • Maternal antibodies: Babies born to vaccinated mothers have antibodies passed to them via breastmilk a shorter time compared to mothers who have natural immunity from the wild virus. Therefore, vaccination leaves infants of future generations vulnerable to measles during infancy, when they are most susceptible to a severe case. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2249400/ 

Reported side effects:


Autism:

  • “Regarding the autism controversy, the primary worry for parents is that many cases of autism appear between ages one and two, and we don’t know why… We don’t know what it is about this second year of life that triggers this regressive autism, but some parents with affected children blame vaccines, and some blame the MMR vaccine in particular, given at one year. On page 265, I discuss the option of delaying the MMR vaccine until a toddler has grown past this susceptible year. This ensures that a child is protected by the time he or she is around large groups of children every day, in daycare or preschool” (Sears, pg. 95).
  • Out of 23 vaccine/Autism studies done by 2011, 18 of them were funded by vaccine manufacturers who would be held liable if a link was found. (Sears, pg 188)
  • Autism and MMR studies:
    https://www.ncbi.nlm.nih.gov/pubmed/1214553

https://academicjournals.org/journal/JPHE/article-abstract/C98151247042

https://www.ncbi.nlm.nih.gov/pubmed/26103708

MMR vaccine failures:

Disease Risk vs. Vaccine Risk

Vitamin A (pg. 248-256)

  • The WHO and the AAP recommend the following high dose vitamin A treatment for measles with one dose given at diagnosis and a second dose the following day:
    Age one and up: 200,000 IU
    Ages 6-12 months: 100,000 IU
    Younger than 6 months: 50,000 IU
    (    Miller’s Review of Critical Vaccine Studies, pg 250)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1245303/
https://www.ncbi.nlm.nih.gov/pubmed/12521271
https://www.ncbi.nlm.nih.gov/pubmed/1951162
https://www.ncbi.nlm.nih.gov/pubmed/16235283
https://www.ncbi.nlm.nih.gov/pubmed/2194128
https://www.ncbi.nlm.nih.gov/pubmed/1285727
https://www.ncbi.nlm.nih.gov/pubmed/1565535
https://www.ncbi.nlm.nih.gov/pubmed/8133555

More information:
https://www.nvic.org/vaccines-and-diseases/measles/measles-vaccine-injury-death.aspx#_edn17 

Summary:

Severe reactions are more common with MMR and MMR-V than other vaccines. Safety studies have been called inadequate by the Cochrane Collaborative. Mumps and rubella are mild illnesses in childhood, with rubella being dangerous around pregnant mothers to their unborn children. Measles is rarely severe in childhood, and it is treated with high dose vitamin A. In addition, natural immunity to these illnesses lasts longer than vaccine immunity and provides reduced risk of heart attack, stroke, and some cancers in adulthood. Breastfed infants of naturally immune mothers have maternal antibodies longer than breastfed infants of vaccinated mothers.

Risk of SIDS

Several studies show that the risk of SIDS increases in vaccinated infants. According to Miller’s Review of Critical Vaccine Studies, this risk increases when using combination vaccines. Autopsies of vaccinated infants who died from SIDS showed brain abnormalities. (Pgs 223-227)


58% of SIDS cases were reported 3 days after vaccinations.
78% of SIDS cases were reported within 7 days after vaccinations.
https://www.sciencedirect.com/science/article/pii/S2214750021001268 

Premature Infants

According to Miller’s Review of Critical Vaccine Studies, Many preterm infants are vaccinated according to age by birth, like term infants, rather than gestational age. However, studies show that preterm infants have immunological immaturity, which decreases vaccine efficacy (pg 219). Preterm infants have a higher risk of adverse reactions, including sepsis and cardiorespiratory problems such as bradycardia and apnea (pgs 212-221). Some doctors suggest that premature infants should be monitored for 72 hours after vaccination due to the increase of adverse events. (pg 215).  

If adverse reactions are more likely in preterm infants, and if vaccine efficacy is less likely in preterm infants, why are doctors vaccinating them as they vaccinate term infants, and why are doctors not warning parents of these risks?